This book describes the way that pharmaceutical projects and programs are currently managed, and offers views from many highly experienced practitioners from within the industry on future directions for drug program management. The book integrates portfolio, program, and project management processes
Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries
- Year
- 2010
- Tongue
- English
- Leaves
- 336
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
This book describes the way that pharmaceutical projects and programs are currently managed, and offers views from many highly experienced practitioners from within the industry on future directions for drug program management. The book integrates portfolio, program, and project management processes as fundamental for effective and efficient drug product development. Contributing expert authors provide their view of how the projectization approach can be taken forward by the drug industry over the coming years.Content:
Chapter 1 A Review of Project Management in Life Science Industry Sectors (pages 3β19): Thomas R. Dunson
Chapter 2 The Impact of Organizational Size on Drug Project Management (pages 21β32): Eric Morfin
Chapter 3 Drug Development in Biotechnology and How We Can Do It Better (pages 33β47): Susan Linna
Chapter 4 An Overview of the Organization and Processes of Portfolio, Program, and Project Management (pages 53β57): Pete Harpum
Chapter 5 Portfolio Management in the Pharmaceutical Industry: Balancing Corporate Need with the Reality of Delivering Products to the Market (pages 59β83): Dr. John Bennett
Chapter 6 Program Management in Drug Development (pages 85β99): Pauline Stewart?Long
Chapter 7 Project Control (pages 101β134): Martin Powell
Chapter 8 Managing Uncertainty in Drug Projects (pages 135β153): Pete Harpum and Thomas R. Dunson
Chapter 9 Managing Drug Safety Risk (pages 155β174): Thomas R. Dunson and Eric Morfin
Chapter 10 Developing Program Strategy (pages 175β196): Pete Harpum
Chapter 11 Developing Products with βAdded Valueβ (pages 197β224): Trevor J. Brown and Stephen Allport
Chapter 12 Integrated Business Processes to Support Cross?Functional Drug Development (pages 227β238): Martin D. Hynes
Chapter 13 Integrated Drug Development: From Cradle to Grave and from Lab to Market (pages 239β258): Stephen Allport and Terry Cooke?Davies
Chapter 14 The Development of P3M Capability in Drug Development Organizations (pages 259β285): John Arrowsmith, Patrick Grogan and Bob Moore
Chapter 15 Implementing Portfolio, Program, and Project Management Best Practices in Drug Development Organizations (pages 287β309): Pete Harpum, Ashley Jamieson and Inge Fisher
β¦ Table of Contents
ffirs01.pdf......Page 1
ffirs02.pdf......Page 4
flast01.pdf......Page 9
flast02.pdf......Page 10
c01.pdf......Page 18
π SIMILAR VOLUMES
Includes bibliographical references and index
This is an update and expansion upon PMI's popular reference, The Practice Standard for Project Risk Management. Risk Management addresses the fact that certain events or conditions may occur with impacts on project, program, and portfolio objectives. This standard will: identify the core principles
Book annotation not available for this title.<br><b>Title: </b>Middle Managers in Program and Portfolio Management<br><b>Author: </b>Blomquist, Tomas/ Muller, Ralf<br><b>Publisher: </b>Project Management Inst<br><b>Publication Date: </b>2006/04/12<br><b>Number of Pages: </b><br><b>Binding Type: </b>